Dopamine D2 Long Receptor-Deficient Mice Display Alterations in Striatum-Dependent Functions

The dopamine D2 receptor (D2) system has been implicated in several neurological and psychiatric disorders, such as schizophrenia and Parkinson's disease. There are two isoforms of the D2 receptor: the long form (D2L) and the short form (D2S). The two isoforms are generated by alternative splicing of the same gene and differ only by 29 amino acids in their protein structures. Little is known about the distinct functions of either D2 isoform, primarily because selective pharmacological agents are not available. We generated D2L receptor-deficient (D2L−/−) mice by making a subtle mutation in the D2 gene. D2L−/− mice (which still express functional D2S) displayed reduced levels of locomotion and rearing behavior. Interestingly, haloperidol produced significantly less catalepsy and inhibition of locomotor activity in D2L−/− mice. These findings suggest that D2L and D2S may contribute differentially to the regulation of certain motor functions and to the induction of the extrapyramidal side effects associated with the use of typical antipsychotic drugs (e.g., haloperidol). Quinpirole induced a similar initial suppression of locomotor activity in both D2L−/− and wild-type mice. In addition, the D2S receptor in the mutant mice functioned approximately equally well as did D2L as an impulse-modulating autoreceptor. This suggests that the functions of these two isoforms are not dependent on the formation of receptor heterodimers. Our findings may provide novel information for potentially developing improved antipsychotic drugs.

[1]  H. Kung,et al.  Quantitative autoradiographic studies of dopamine D3 receptors in rat cerebellum using [125I]S(−)5-OH-PIPAT , 1997, Brain Research.

[2]  D. Eilam,et al.  Biphasic effect of D-2 agonist quinpirole on locomotion and movements. , 1989, European journal of pharmacology.

[3]  M. Sanghera,et al.  Electrophysiological properties of mouse dopamine neurons: In vivo and in vitro studies , 1984, Neuroscience.

[4]  G. Aghajanian,et al.  Molecular and cellular basis of addiction. , 1997, Science.

[5]  D. Grandy,et al.  Cloning and expression of a rat D2 dopamine receptor cDNA , 1988, Nature.

[6]  D. Grandy,et al.  Molecular diversity of the dopamine receptors. , 1993, Annual review of pharmacology and toxicology.

[7]  P. Molinoff,et al.  Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells. , 1996, The Journal of pharmacology and experimental therapeutics.

[8]  D. Sibley,et al.  Molecular neurobiology of dopaminergic receptors. , 1993, International review of neurobiology.

[9]  P. Seeman,et al.  Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors , 1998, Molecular Psychiatry.

[10]  M. Martres,et al.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms , 1989, Nature.

[11]  Kenji Nakamura,et al.  Dopamine 02 receptor plays a critical role in cell proliferation and proopiomelanocortin expression in the pituitary , 1996, Genes to cells : devoted to molecular & cellular mechanisms.

[12]  G. Aghajanian,et al.  Excitation of locus coeruleus neurons by an adenoine 3′,5′‐cyclic monophosphate‐activated inward current: Extracellular and intracellular studies in rat brain slices , 1987, Synapse.

[13]  M. Yahr Biochemistry and pharmacology of the basal ganglia , 1965 .

[14]  G. F. Hess,et al.  A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus , 1990, Nature.

[15]  R. Pertwee The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice , 1972, British journal of pharmacology.

[16]  P. Strange,et al.  [3H]Nemonapride and [3H]Spiperone Label Equivalent Numbers of D2 and D3 Dopamine Receptors in a Range of Tissues and Under Different Conditions , 1995, Journal of neurochemistry.

[17]  G. Aghajanian,et al.  Excitation of locus coeruleus neurons by vasoactive intestinal peptide: role of a cAMP and protein kinase A , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  Alcino J. Silva,et al.  Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. , 1992, Science.

[19]  P. Calabresi,et al.  Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. , 1997, Neuroscience.

[20]  K. Neve,et al.  Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  B. Sommer,et al.  The dopamine D2 receptor: two molecular forms generated by alternative splicing. , 1989, The EMBO journal.

[22]  A. Saiardi,et al.  Dopamine D2 receptors in signal transduction and behavior. , 1997, Critical reviews in neurobiology.

[23]  M. Kelly,et al.  Tolerance of hypothalamic beta-endorphin neurons to mu-opioid receptor activation after chronic morphine. , 1996, Journal of Pharmacology and Experimental Therapeutics.

[24]  R. G. Allen,et al.  Pituitary Lactotroph Hyperplasia and Chronic Hyperprolactinemia in Dopamine D2 Receptor-Deficient Mice , 1997, Neuron.

[25]  山口 浩雄 Dopamine D2 receptor plays a critical role in cell proliferation and proopiomelanocortin expression in the pituitary , 1996 .

[26]  F. J. White,et al.  Alterations in Dopamine Release But Not Dopamine Autoreceptor Function in Dopamine D3 Receptor Mutant Mice , 1998, The Journal of Neuroscience.

[27]  R. Todd,et al.  The Mouse Dopamine D2A Receptor Gene: Sequence Homology with the Rat and Human Genes and Expression of Alternative Transcripts , 1991, Journal of neurochemistry.

[28]  D. Weinberger,et al.  Dopamine and schizophrenia—a cortically corrective perspective , 1992 .

[29]  N. Mercuri,et al.  Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. , 1987, The Journal of physiology.

[30]  G. Aghajanian,et al.  Excitation of locus coeruleus neurons by vasoactive intestinal peptide: evidence for a G-protein-mediated inward current , 1989, Brain Research.

[31]  H. Kung,et al.  Characterization of [125I]S(−)5-OH-PIPAT binding to dopamine D2-like receptors expressed in cell lines , 1997, Neuropharmacology.

[32]  A. Saiardi,et al.  Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors , 1995, Nature.

[33]  Marc G Caron,et al.  Dopamine receptors and brain function , 1996, Neuropharmacology.

[34]  A. Grace,et al.  Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—1. Identification and characterization , 1983, Neuroscience.

[35]  R. Pinnock The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra , 1984, British journal of pharmacology.

[36]  Bruno Giros,et al.  Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA , 1991, Brain Research.

[37]  S. Snyder,et al.  Catecholamines in the brain as mediators of amphetamine psychosis. , 1972, Archives of general psychiatry.

[38]  C. Stevens,et al.  Changes in reliability of synaptic function as a mechanism for plasticity , 1994, Nature.

[39]  R. Roth,et al.  Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. , 1973, The Journal of pharmacology and experimental therapeutics.

[40]  M. Low,et al.  Locomotor Activity in D2 Dopamine Receptor-Deficient Mice Is Determined by Gene Dosage, Genetic Background, and Developmental Adaptations , 1998, The Journal of Neuroscience.

[41]  F. J. White,et al.  Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. , 1984, The Journal of pharmacology and experimental therapeutics.

[42]  M. Caron,et al.  Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. , 1988, The Journal of biological chemistry.

[43]  Ming Xu,et al.  Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses , 1994, Cell.

[44]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[45]  D. Roberts,et al.  The quantitative measurement of motor inco‐ordination in naive mice using an accelerating rotarod , 1968 .

[46]  H. Steiner,et al.  Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin , 1996, Nature.

[47]  S. Senogles The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gi alpha proteins. , 1994, The Journal of biological chemistry.

[48]  C. Gerfen,et al.  Multiple D2 dopamine receptors produced by alternative RNA splicing , 1989, Nature.

[49]  A M Graybiel,et al.  The basal ganglia and adaptive motor control. , 1994, Science.

[50]  A. Carlsson,et al.  Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease , 1990, Trends in Neurosciences.

[51]  Hee-Sup Shin,et al.  Mutant Mice and Neuroscience: Recommendations Concerning Genetic Background , 1997, Neuron.

[52]  E. Borrelli,et al.  Alternative Splicing of the Dopamine D2 Receptor Directs Specificity of Coupling to G-proteins (*) , 1995, The Journal of Biological Chemistry.

[53]  Y. Mizuki,et al.  Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice. , 1995, European journal of pharmacology.